Natera, Inc.
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as tw…
Medical - Diagnostics & Research
US, San Carlos [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -73.81 | -170.55 | -98.13 | |
| Graham Fair Price | -6.38 | 9.10 | 9.72 | |
| PEG | 295.65 | 3.00 | 0.76 | |
| Price/Book | 44.84 | 14.14 | 9.76 | |
| Price/Cash Flow | 1420.78 | 1679.76 | -110.45 | |
| Prices/Earnings | -73.48 | -41.53 | -23.94 | |
| Price/Sales | 27.14 | 30.54 | 24.02 | |
| Price/FCF | 1420.78 | 1679.76 | -110.45 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 10.39 | 0.57 | 0.51 | |
| Operating Margin | 25.63 | -0.20 | -0.27 | |
| ROA | 14.02 | -0.05 | -0.05 | |
| ROE | -0.10 | -0.09 | 16.51 | |
| ROIC | -0.07 | -0.06 | 13.97 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | < 0.005 | 0.02 | -79.83 | |
| Dividends QOQ | 0.00 | 0.00 | 0.00 | |
| EBIT QOQ | 0.24 | 0.12 | -49.26 | |
| EPS QOQ | 0.32 | 0.14 | -56.15 | |
| FCF QOQ | -0.75 | 1.10 | 46.46 | |
| Revenue QOQ | 0.16 | 0.18 | 14.13 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Balanced
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 24.25 | 24.33 | 0.32 | |
| Days Sales Outstanding (DSO) | 80.51 | 70.67 | -12.22 | |
| Inventory Turnover | 3.71 | 3.70 | -0.32 | |
| Debt/Capitalization | 0.33 | 0.32 | -2.35 | |
| Quick Ratio | 3.77 | 3.83 | 1.68 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 6.42 | 6.57 | 2.46 | |
| Cash | 7.37 | 7.31 | -0.81 | |
| Capex | -0.08 | -0.17 | -110.45 | |
| Free Cash Flow | -0.57 | 0.06 | -90.24 | |
| Revenue | 2.61 | 3.04 | 16.72 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Weak
Fundamentals
Financial Health
06 - Financial Health ·
Bad